Xiangjun Zhou, Ph.D., HRYZ BIOTECH CO. Board member and Chief Scientific Officer. Well-known for his contributions in the field of gene therapy and cancer immunotherapy.
1985 BS of Biology, SUN YAT-SEN UNIVERSITY, Guangzhou, China,
1994 MS of Pharmacology, University of Hawaii School of Medicine, Department of Pharmacology, USA,
1997 Ph. D. of Biomedical Science, University of Hawaii School of Medicine, USA,
2000 Post doctoral fellow in Cell Biology, Stanford University School of Medicine Department of Medicine, USA.
Lead many important national research grants, Including 863 grants and one 973 grant, Over 20 Publications in Journals such as Science, Journal of Clinical Investigation, Journal of Cell Science, Journal of Biological Chemistry,Filed 10 Patents including US patents such as “Cell-free protein synthesis system with protein translocation and processing”, Patent No: 6,103,489 (Aug. 15, 2000) and China Patents such as “SARS Vaccine”.